NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
12.53 USD
+0.53 (+4.42%)
Taking everything into account, NUS scores 5 out of 10 in our fundamental rating. NUS was compared to 36 industry peers in the Personal Care Products industry. NUS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. NUS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
NUS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NUS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of NUS (6.98%) is better than 69.44% of its industry peers.
NUS has a better Return On Equity (12.80%) than 77.78% of its industry peers.
With a Return On Invested Capital value of 3.88%, NUS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 12.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS's Profit Margin of 6.20% is fine compared to the rest of the industry. NUS outperforms 72.22% of its industry peers.
The Operating Margin of NUS (3.51%) is comparable to the rest of the industry.
NUS's Operating Margin has declined in the last couple of years.
NUS has a Gross Margin (67.23%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
The number of shares outstanding for NUS has been increased compared to 1 year ago.
Compared to 5 years ago, NUS has less shares outstanding
NUS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.82 indicates that NUS is not in any danger for bankruptcy at the moment.
NUS has a better Altman-Z score (3.82) than 66.67% of its industry peers.
NUS has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.61, NUS belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
NUS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, NUS is in line with its industry, outperforming 52.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.82 |
ROIC/WACC0.51
WACC7.63%
2.3 Liquidity
NUS has a Current Ratio of 2.01. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.01, NUS is in line with its industry, outperforming 55.56% of the companies in the same industry.
NUS has a Quick Ratio of 1.38. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.38, NUS is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
NUS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.63%.
NUS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.85% yearly.
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -11.80% in the last year.
The Revenue has been decreasing by -6.47% on average over the past years.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
The Earnings Per Share is expected to grow by 36.15% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -5.71% on average over the next years.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.36, the valuation of NUS can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, NUS is valued rather cheaply.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 7.95.
Based on the Price/Forward Earnings ratio, NUS is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
NUS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.64.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.36 | ||
| Fwd PE | 7.95 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.67% of the companies listed in the same industry.
NUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.51 | ||
| EV/EBITDA | 4.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 36.15% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 1.95%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.62, NUS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.95% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
11.83% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
NYSE:NUS (9/26/2025, 10:46:09 AM)
12.53
+0.53 (+4.42%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.35%
Inst Owner Change-2.56%
Ins Owners2.16%
Ins Owner Change3.24%
Market Cap620.24M
Analysts45
Price Target7.65 (-38.95%)
Short Float %3.99%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.95% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.36 | ||
| Fwd PE | 7.95 | ||
| P/S | 0.38 | ||
| P/FCF | 1.51 | ||
| P/OCF | 1.39 | ||
| P/B | 0.79 | ||
| P/tB | 0.94 | ||
| EV/EBITDA | 4.88 |
EPS(TTM)1.21
EY9.66%
EPS(NY)1.58
Fwd EY12.57%
FCF(TTM)8.3
FCFY66.26%
OCF(TTM)9
OCFY71.86%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.21
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexcg growth 3Y-45.58%
ROICexcg growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.82 |
F-Score6
WACC7.63%
ROIC/WACC0.51
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%